A phase II study of antithymocyte globulin in patients undergoing HLA-matched allogeneic peripheral blood stem cell transplantation - JSCT-ATG15

JSCT0 个研究点目标入组 77 人开始时间: 2015年10月1日最近更新: 2023年10月17日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 77

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

ow-dose ATG as a GVHD prophylaxis showed safety and efficacy for the prevention of both acute and chronic GVHD in HLA-matched PBSCT using myeloablative conditioning.

研究设计

研究类型: Interventional

入排标准

年龄范围: 15years-old 至 60years-old（—）
性别: All

入选标准

未提供

排除标准

•1. Patients who are positive for HIV antibody. 2. Patients with active other malignancies. 3. Patients with active infectious disease. 4. Women who are pregnant, of childbearing potential, or lactating. 5. Patients who experienced serious hypersensitivity or anaphylaxis to antithymocyte globulin. 6. Patients who has a prior history of allogeneic transplantation. 7. Patients who are not eligible for this study at the discretion of the investigator.

研究者

发起方

JSCT

相似试验

已完成

4 期

Efficacy and Safety Study of ATG for Prophylaxis of aGVHD in Matched Sibling Donor PBSCTaGVHD

NCT02677181Chinese PLA General Hospital100

已完成

2 期

Antithymocyte Globulin and Cyclosporine to Treat MyelodysplasiaMyelodysplastic Syndrome

NCT00005937Neal Young, M.D.42

终止

2 期

Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant PatientsChronic Myelogenous Leukemia, BCR-ABL1 PositiveDiffuse Large B-Cell LymphomaGraft Versus Host DiseaseChronic Lymphocytic LeukemiaMarginal Zone LymphomaMyeloproliferative NeoplasmSmall Lymphocytic LymphomaMyelodysplastic SyndromeAcute LeukemiaFollicular LymphomaMyelofibrosisMantle Cell Lymphoma

NCT02877082Emory University5

已完成

3 期

Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)Graft vs Host Disease

NCT00655343Neovii Biotech202

Unknown

2 期

Efficacy and Safety Study of 4-Day ATG Regimen for Prophylaxis of aGVHD in Matched Sibling Donor PBSCTaGVHDcGVHD

NCT05214066Chinese PLA General Hospital60